DOI 10.1016/j.ejmech.2025.118500
Neutral sp2-iminosugars exploiting non-glycone interactions for selective acid α- and β-glucosidase activity modulation: Pharmacological chaperones for Gaucher and Pompe diseases.
Аннотация
A major challenge in developing selective active site-directed pharmacological chaperones for lysosomal storage disorders is discriminating among glycosidases acting on anomeric substrates. Here, we report the design and synthesis of neutral thiourea-type sp2-iminosugars derived from 1-deoxynojirimycin to rescue the activity of mutant variants of human acid β-glucosidase (GCase) and acid α-glucosidase (GAA) implicated in Gaucher disease (GD) and Pompe disease (PD), respectively. Structural diversification at the non-glycone substituents enabled fine-tuning of hydrophobic and π-stacking interactions, leading to selective enzyme targeting. In vitro assays and cell-based models demonstrated that aromatic derivatives restored GAA activity, improved autophagic flux, and normalized lysosomal trafficking in PD cells (HAP1-p.G549R cells), whereas aliphatic derivatives enhanced GCase activity and corrected mitochondrial dysfunction in GD fibroblasts (p.F213I and p.N370S fibroblasts). Notably, the N'-(p-methoxyphenyl)thiourea derivative exhibited dual activity, rescuing both GAA and GCase mutants without affecting wild-type enzymes. These results identify neutral thiourea-type sp2-iminosugars as promising scaffolds for next-generation pharmacological chaperones with enhanced selectivity and reduced off-target effects.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.